Stocks of Boston Scientific - Current price, Where to buy? Chart
| Detail | Data |
|---|---|
| Stocks: | Boston Scientific |
| ompany Name: | Boston Scientific Corporation |
| Ticker: | BSX |
| Exchange: | NYSE |
| Outstanding stocks: | 1,470,179,968 |
| 24-hour Volume: | 6,366,290 |
| Industry: | Medical Devices |
| Sector: | Healthcare |
| Number of Employees: | 48000 |
| Country: | United States |
| City: | Marlborough |
| Address: | 300 Boston Scientific Way |
| P/E Ratio: | Forward P/E | EPS: | Forward EPS | Book value per share | Market capitalization |
|---|---|---|---|---|---|
| 60.39 | 27.22 | 1.19 USD | 2.64 USD | 13.16 USD | 105,897,058,304.00 USD |
| P/E Ratio: | 60.39 |
|---|---|
| Forward P/E: | 27.22 |
| EPS: | 1.19 USD |
| Forward EPS: | 2.64 |
| Book value per share: | 13.16 USD |
| Market capitalization: | 105,897,058,304.00 USD |
Boston Scientific
Fundamental Indicators
| Indicator | Data |
|---|---|
| Total Revenue: | 14,707,000,320.00 USD |
| Net Income: | 1,764,999,936.00 USD |
| Price-to-Book (P/B) Ratio: | 5.46 |
| PEG Ratio: | 2.51 |
Note: The data is approximate, subject to change over time, and may not be current; however, we strive for the highest possible accuracy.
Analysts' predictions
| Analysts | Recommendation |
|---|---|
| Issued Recommendation: | According to our data, the recommendation issued for Boston Scientific stocks is: buy |
| Number of Analysts: | 29 |
| Highest Target Price: | 90 USD |
| Lowest Target Price: | 73 USD |
| Average Target Price: | 82 USD |
Note: The data is approximate. Recommendations and price forecasts for Boston Scientific stocks based on analysts' ratings may change over time. Some recommendations may already be outdated and may not be accurate. We strongly advise against buying and selling stocks based on analysts' recommendations!
Dividend
| Dividends | Value |
|---|---|
| Dividend Amount | According to our data, the company Boston Scientific is currently not paying dividends. |
| Annual Yield %: | - |
| Ex-dividend Date: | - |
| Average % Yield for 5 Years: | - |
| Payout Ratio: | - |
| Value of Last Dividend Paid: | - |
| Date of Last Dividend: | - |
The dividend is displayed for the entire calendar year, however, it is usually paid out quarterly in parts. Data may change!
Where to Buy Boston Scientific Stocks?
If you're interested in investing in Boston Scientific stocks and believe in their future growth, you can purchase them through stock brokers like XTB or eToro. To make buying easier, we've prepared a table with offers from these brokers, including quick purchase of Boston Scientific stocks through mobile apps with client support. In this table, you can compare brokers offering real Boston Scientific stocks. Brokers providing the option to buy real stocks (not CFDs) are identified by "Real Stocks" in the comparison table column.
| Broker | Platforms | Regulation | Min. Deposit | Deposits / Withdrawals | CopyTrader | Real Stocks | Website Link |
|---|---|---|---|---|---|---|---|
 |
Proprietary platform, social network + CopyTrader™ | 100 USD | Bank transfer, credit cards, Skrill, PayPal, Neteller |
 Go to eToro
|
|||
 |
xStation, mobile version | 10 USD | Credit cards, Skrill, bank transfer |
 Go to XTB
|
|
|
| xStation, mobile version | Proprietary platform, social network + CopyTrader™ |
|
Go to XTB
|
Go to eToro
|
More Information about Boston Scientific (BSX)
Boston Scientific consistently proves itself as a leader in its industry. Total revenues for the last 12 months exceed 14,707,000,320.00 USD, demonstrating its strong market position and ability to generate high revenues. With EBITDA reaching 3,744,000,000.00 USD, Boston Scientific maintains a high level of efficiency and profitability. This highlights its ability to manage operational costs effectively. Debt-to-equity ratio of 0.49 suggests that Boston Scientific has a healthy financial structure and effectively manages its debts. This is key to stable growth. Gross margin of 69.05% shows that Boston Scientific efficiently manages costs and maintains a high share of revenues. This is a sign of a strong market position. Lower profit margin of 12.06% suggests opportunities for Boston Scientific to increase efficiency and reduce costs.
| Indicator | Value |
|---|---|
| Revenue, Debt, and Cash Flow | |
| Company Revenue: | 14,707,000,320.00 USD |
| EBITDA: | 3,744,000,000.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization. |
| Earnings Per Share: | 1.19 USD |
| Book Value Per Share: | 13.16 USD |
| Total Cash: | 865,000,000.00 USD |
| Total Cash per Share: | 0.59 USD |
| Total Debt: | 9,568,000,000.00 USD |
| Debt to Equity Ratio: | 0.49 |
| Quick Ratio: | / |
| Current Ratio: | / |
| Free Cash Flow: | / |
| Operating Cash Flow: | / |
| Company Margins | |
| Gross Margins: | 69.05 % |
| EBITDA Margins: | 25.46 % |
| Operating Margins: | 18.88 % |
| Profit Margins: | 12.06 % |
| Performance | |
| Return on Assets: | / |
| Return on Equity: | / |
| Earnings Growth (1 year): | 57.9% |
| Revenue Growth (1 year): | 13.8 % |
| Year-over-Year Quarterly Earnings Growth: | 57.6 % |
| Valuation | |
| Market Capitalization: | 105,897,058,304.00 USD |
| Enterprise Value: | 115,315,433,472.00 USD |
| EV/Revenue: | 7.841 |
| EV/EBITDA: | 30.8 |
| Number of Shares and Short Shares | |
| Float Shares: | 1,462,195,528 shares |
| Shares Outstanding: | 1,469,900,032 shares |
| Held Percent Insiders: | 0.00 % |
| Held Percent Institutions: | 94.49 % |
| Shares Short: | 13,159,314 |
| Shares Short Prior Month: | 11,481,707 |
| Date Short Interest: | 2024-04-15 |
| Shares Percent Shares Out: | 0.90 % |
| Short Ratio: | 2.50 |
| Beta: | 0.79 |
| Short Percent of Float: | 0.90 % |
| Předpokládaný počet akcií: | 1,469,900,032 |
Frequently Asked Questions (FAQ)
According to our data, Boston Scientific does not currently pay dividends, even in 2024.
Boston Scientific shares are traded on the stock exchange NYSE under the ticker symbol: BSX. You can buy or trade them with a variety of stock brokers offering real stock trading services.
According to our data, there is a buy recommendation issued for Boston Scientific shares by a total of 29 analysts. The average target price prediction is 82 USD per share.
The total number of Boston Scientific shares on the exchange is 1,469,900,032.00, which, at the current market capitalization, values the company at 105,897,058,304.00 USD.
